161
Views
24
CrossRef citations to date
0
Altmetric
Drug Profile

Alemtuzumab for B-cell chronic lymphocytic leukemia

Pages 1033-1051 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emanuele D’Amico, Cinzia Caserta & Francesco Patti. (2015) Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives. Expert Review of Neurotherapeutics 15:3, pages 251-268.
Read now
Tadeusz Robak, Ewa Lech-Maranda & Pawel Robak. (2010) Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 10:10, pages 1529-1543.
Read now

Articles from other publishers (22)

Alok K. Mishra. 2023. Phagocytosis - Main Key of Immune System. Phagocytosis - Main Key of Immune System.
Gexuan Jiang, Zhichu Xiang & Qiaojun Fang. (2023) Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy. Nanoscale Horizons 8:8, pages 1062-1072.
Crossref
Maciej Borówka, Stanisław Łącki-Zynzeling, Michał Nicze, Sylwia Kozak & Jerzy Chudek. (2022) Adverse Renal Effects of Anticancer Immunotherapy: A Review. Cancers 14:17, pages 4086.
Crossref
Daiki Makieda, Satoru Esumi & Kiminaka Murakawa. (2021) Drug interaction (51. New oral anticancer drugs in hematological malignancies and drug interactions)薬物相互作用(51―造血器腫瘍領域の新規経口抗がん剤と薬物相互作用). Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 133:2, pages 120-126.
Crossref
Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi, Behzad Baradaran & Leili Aghebati-Maleki. (2018) Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody. Human Antibodies 26:1, pages 1-6.
Crossref
Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi, Behzad Baradaran, Leili Aghebati-Maleki, Farzaneh Fathi & Jafar Ezzati Nazhad Dolatabadi. (2017) Immuno-biosensor for Detection of CD20-Positive Cells Using Surface Plasmon Resonance. Advanced Pharmaceutical Bulletin 7:2, pages 189-194.
Crossref
Erwin De Genst, Dimitri Y. Chirgadze, Fabrice A.C. Klein, David C. Butler, Dijana Matak-Vinković, Yvon Trottier, James S. Huston, Anne Messer & Christopher M. Dobson. (2015) Structure of a Single-Chain Fv Bound to the 17 N-Terminal Residues of Huntingtin Provides Insights into Pathogenic Amyloid Formation and Suppression. Journal of Molecular Biology 427:12, pages 2166-2178.
Crossref
Tadeusz Robak. (2013) Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia. Future Oncology 9:1, pages 69-91.
Crossref
Tadeusz Robak. (2012) Przeciwciała monoklonalne w leczeniu przewlekłej białaczki limfocytowej. Acta Haematologica Polonica 43:2, pages 99-106.
Crossref
A. Safdar & D. Armstrong. (2011) Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic Defects. Clinical Infectious Diseases 53:8, pages 798-806.
Crossref
Vinochani Pillay, Hui K. Gan & Andrew M. Scott. (2011) Antibodies in oncology. New Biotechnology 28:5, pages 518-529.
Crossref
Leandro F.F. Dalmazzo, Bárbara A. Santana-Lemos, Rafael H. Jácomo, Aglair B. Garcia, Eduardo M. Rego, Luiz M. da Fonseca & Roberto P. Falcão. (2011) Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies. Leukemia Research 35:5, pages 657-662.
Crossref
Charlotte C. PetersenLine NederbyAnne S. RougAnni SkovboNiels A. PeterslundPeter HoklandBendt NielsenMarianne Hokland. (2011) Increased Expression of CD69 on T Cells as an Early Immune Marker for Human Cytomegalovirus Reactivation in Chronic Lymphocytic Leukemia Patients. Viral Immunology 24:2, pages 165-169.
Crossref
Tadeusz Robak. (2011) Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment. Cancer Treatment Reviews 37:1, pages 3-10.
Crossref
Jan W. Gratama, Cor H. J. Lamers & Reno Debets. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology 151 178 .
André Goy & Susan O’Brien. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases 47 66 .
Margaret T. Kasner. (2010) Novel Targets for Treatment of Adult Acute Lymphocytic Leukemia. Current Hematologic Malignancy Reports 5:4, pages 207-212.
Crossref
Małgorzata Rogalińska, Jerzy Z. Błoński, Oxana Komina, Paweł Góralski, Jolanta D. Żołnierczyk, Henryk Piekarski, Tadeusz Robak, Zofia M. Kiliańska & Józefa Węsierska-Gądek. (2010) R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. Journal of Cellular Biochemistry 109:1, pages 217-235.
Crossref
Tadeusz Robak, Krzysztof Jamroziak & Pawel Robak. (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69:17, pages 2415-2449.
Crossref
Christel VangestelChristophe Van de WieleGilles MeesMarc Peeters. (2009) Forcing Cancer Cells to Commit Suicide. Cancer Biotherapy and Radiopharmaceuticals 24:4, pages 395-407.
Crossref
Tadeusz Robak. (2009) Ofatumumab for the treatment of chronic lymphocytic leukemia. Therapy 6:4, pages 577-587.
Crossref
Tadeusz Robak. (2008) Treatment of chronic lymphoid leukemias with monoclonal antibodies: current place and perspectives. Drug Development Research 69:7, pages 373-387.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.